SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-017273
Filing Date
2022-06-21
Accepted
2022-06-21 08:35:27
Documents
18
Period of Report
2022-06-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 40822
2 ex10-1.htm EX-10.1 504308
3 ex10-1_001.jpg GRAPHIC 332533
4 ex10-1_002.jpg GRAPHIC 57922
5 ex10-1_003.jpg GRAPHIC 223920
6 ex99-1.htm EX-99.1 10942
7 ex99-1_001.jpg GRAPHIC 4114
  Complete submission text file 0001493152-22-017273.txt   1660936

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE aim-20220616.xsd EX-101.SCH 2959
9 XBRL LABEL FILE aim-20220616_lab.xml EX-101.LAB 34916
10 XBRL PRESENTATION FILE aim-20220616_pre.xml EX-101.PRE 22790
12 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3664
Mailing Address 2117 SW HIGHWAY 484 OCALA FL 32801
Business Address 2117 SW HIGHWAY 484 OCALA FL 32801 352-448-7797
AIM ImmunoTech Inc. (Filer) CIK: 0000946644 (see all company filings)

IRS No.: 520845822 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-27072 | Film No.: 221026219
SIC: 2836 Biological Products, (No Diagnostic Substances)